However, the combination of the increasing LIP and ROS levels via mitochondrial iron translocation blockage and diminishing mitochondrial oxygen consumption and glycolysis upon DMT1 silencing could be at the basis of the acquisition of enhanced outgrowth metastatic capacity upon DMT1 ablation in MDA-MB-231 breast cancer cells. Here, SLC11A2 is linked to breast carcinoma.